Calcium Phosphorus Nanoparticles Coloaded with Paclitaxel and ADAM-10-siRNA for the Treatment of Triple Negative Breast Cancer
Author:
Affiliation:
1. Department of Medical Oncology, The First Affiliated Hospital of Wannan Medical College, Wuhu, China
2. Department of Medical Oncology, Wuhu Hospital Affiliated to East China Normal University, Wuhu, China
Abstract
Funder
Wannan Medical College
Publisher
Hindawi Limited
Subject
General Materials Science
Link
http://downloads.hindawi.com/journals/jnm/2022/6541132.pdf
Reference32 articles.
1. Targeted Therapies for Triple-Negative Breast Cancer: Combating a Stubborn Disease
2. Pathogenesis of Triple-Negative Breast Cancer
3. Long-term efficacy and safety of addition of carboplatin with or without veliparib to standard neoadjuvant chemotherapy in triple-negative breast cancer: 4-year follow-up data from BrighTNess, a randomized phase III trial
4. The dawn of targeted therapies for triple negative breast cancer (TNBC): a snapshot of investigational drugs in phase I and II trials
5. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3